PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
Keyword(s):
2021 ◽
Vol 30
(3)
◽
pp. 253-263
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19124-e19124
Keyword(s):
2006 ◽
Vol 95
(8)
◽
pp. 998-1004
◽
Keyword(s):
2011 ◽
Vol 47
◽
pp. S591
◽
Keyword(s):
Keyword(s):